Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells
about
Yap1 overproduction restores arsenite resistance to the ABC transporter deficient mutant ycf1 by activating ACR3 expression.Factors determining sensitivity and resistance of tumor cells to arsenic trioxideApoptotic efficacy of etomoxir in human acute myeloid leukemia cells. Cooperation with arsenic trioxide and glycolytic inhibitors, and regulation by oxidative stress and protein kinase activitiesArsenic trioxide triggers a regulated form of caspase-independent necrotic cell death via the mitochondrial death pathway.Enhancement of arsenic trioxide cytotoxicity by dietary isothiocyanates in human leukemic cells via a reactive oxygen species-dependent mechanism.Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: an useful salvage therapy.Phase II study of arsenic trioxide and ascorbic acid for relapsed or refractory lymphoid malignancies: a Wisconsin Oncology Network studyArsenic trioxide downregulates specificity protein (Sp) transcription factors and inhibits bladder cancer cell and tumor growthInhibition of NFkappaB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation.The glycerol channel Fps1p mediates the uptake of arsenite and antimonite in Saccharomyces cerevisiae.NF-kappaB and FLIP in arsenic trioxide (ATO)-induced apoptosis in myelodysplastic syndromes (MDSs)Folate-mediated intracellular drug delivery increases the anticancer efficacy of nanoparticulate formulation of arsenic trioxideSensitivity of leukemic T-cell lines to arsenic trioxide cytotoxicity is dependent on the induction of phosphatase B220/CD45R expression at the cell surface.Opportunities for Trisenox (arsenic trioxide) in the treatment of myelodysplastic syndromes.Resveratrol protects against arsenic trioxide-induced oxidative damage through maintenance of glutathione homeostasis and inhibition of apoptotic progression.A case-control study of GST polymorphisms and arsenic related skin lesions.Arsenic trioxide for the treatment of myelodysplastic syndromes.Expression of survivin in adenoid cystic carcinoma of the lacrimal gland and the effect of intervention with arsenic trioxide in vitroArsenic trioxide: an anti cancer missile with multiple warheads.Lymphokine-activated killer T-cell-originated protein kinase phosphorylation of histone H2AX prevents arsenite-induced apoptosis in RPMI7951 melanoma cells.Arsenic trioxide mechanisms of action--looking beyond acute promyelocytic leukemia.Biological responses to arsenic compoundsAnticancer activity of small-molecule and nanoparticulate arsenic(III) complexes.Darinaparsin: a novel organic arsenical with promising anticancer activity.Zinc finger proteins as templates for metal ion exchange and ligand reactivity. Chemical and biological consequences.Anticancer activity of metal complexes: involvement of redox processes.Effects of Combined Exposure to Chronic High-Fat Diet and Arsenic on Thyroid Function and Lipid Profile in Male Mouse.Arsenic Trioxide and Icariin Show Synergistic Anti-leukemic Activity.Resveratrol synergistically triggers apoptotic cell death with arsenic trioxide via oxidative stress in human lung adenocarcinoma A549 cells.Efficacy of gemtuzumab ozogamicin on ATRA- and arsenic-resistant acute promyelocytic leukemia (APL) cells.Combination of Poly I:C and arsenic trioxide triggers apoptosis synergistically via activation of TLR3 and mitochondrial pathways in hepatocellular carcinoma cells.Pink-eyed dilution protein modulates arsenic sensitivity and intracellular glutathione metabolism.Vitamin C protects HL60 and U266 cells from arsenic toxicity.Arsenic trioxide and reduced glutathione act synergistically to augment inhibition of thyroid peroxidase activity in vitro.In vitro and in vivo effectiveness of arsenic trioxide against murine T-cell prolymphocytic leukaemia.Arsenic trioxide and breast cancer: analysis of the apoptotic, differentiative and immunomodulatory effects.Sustained activation of c-jun-terminal kinase (JNK) is closely related to arsenic trioxide-induced apoptosis in an acute myeloid leukemia (M2)-derived cell line, NKM-1.Dual effects of glutathione-S-transferase pi on As2O3 action in prostate cancer cells: enhancement of growth inhibition and inhibition of apoptosis.Dihydroartemisinin Sensitizes Human Lung Adenocarcinoma A549 Cells to Arsenic Trioxide via Apoptosis.Multifactorial Modes of Action of Arsenic Trioxide in Cancer Cells as Analyzed by Classical and Network Pharmacology.
P2860
Q27936811-9F21D79E-8392-4742-A041-047A3FA41AB3Q28483625-06EF30CE-2C54-4567-B900-FAB997829D3EQ28542724-3DF81D54-600D-462E-94B2-106FC794EAE5Q33211246-5375050A-4D65-478D-9962-B1AA642C331BQ33470967-74580EFC-E6B8-45C1-8A53-4E34CA8B2E68Q33929824-140998B2-F399-4402-A98B-6C8D4BFCFA07Q33962155-9A72D7A1-FE29-4F52-A6EF-5358FEB1F6C2Q33976179-22C2C2E1-0386-4D91-98E5-A91CA6C6D145Q34055763-061D266D-4789-4A3E-AB26-3B96377A9B5CQ34083286-9628897E-E54A-4AAA-BE35-DB98AA51F6FAQ34560200-E2BD3567-7C35-4D94-A88F-BAB322106DD8Q34609485-39F8028E-8996-4E0E-B3B0-285E513198DDQ34611982-3D1EE6EA-C09D-4024-BB8E-A1638E8756B4Q35186892-D5D5F2EF-A286-4640-9563-7048D676380DQ35224476-610F4791-78EF-4F5F-9AED-7BE0FF999D60Q35651816-8F986388-FD80-4176-82E8-C373DBF9E772Q35688178-8FCB6AC1-0175-4DD2-A86E-9CE345F37830Q35803546-E1AD3327-3A7F-4F14-A481-AD0EF0B84165Q36194579-24F264F3-9F92-4293-B9F9-102E0118D2F0Q36453943-86C67222-37D8-4EA3-A1CA-2E05B61330ABQ37307720-CB6A9615-04FF-49C9-B644-7AFEB81142B2Q37442397-8CA9BB7F-6260-4BF0-B600-8B668DB0DEB6Q37486703-CAC6BB89-76AB-4C19-97D8-AFD05F4DF600Q37603342-78462C2C-6EC6-4D70-BC54-BB2AC4844575Q37831171-A3673E20-37E4-4015-94F4-AFF1335CAB02Q37833099-66525A98-3233-40E2-BC73-ED7667207D24Q38737090-20A89E95-708E-4799-BF75-B2735B7F032CQ38905593-A7FD2921-6D75-425D-8000-6B7FCC9C0349Q38937205-D64151A5-B0CE-4F68-9E77-17F3F51A3052Q39506455-8421928F-5838-4F0B-80B5-736EB3F11C11Q39574079-D010EE66-AF92-451E-B50F-283868E9EE26Q39691845-6406D2C6-8500-4AE8-A821-16436A906873Q40464464-202BFDCC-B30A-4CDF-B39F-A8AF474C38B6Q42702868-E861439E-935B-43C0-A858-A5624D5B7669Q43815919-B5A3EDEE-D0C0-435B-A701-D2A3E0BCC4E7Q44040879-D7C0C38B-F038-4047-9605-7FA09B51F495Q44557861-7D3C1D6F-4484-4D7C-8CCD-8AFAC67BA45BQ44790857-7C79E57E-9576-4058-9D8A-F3561FEC088FQ46409037-EB116F7D-ABAD-42CE-84F2-54809FC0B546Q53702218-2218EDF2-C24E-4E25-8116-242CF8E7100E
P2860
Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells
@ast
Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells
@en
Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells
@nl
type
label
Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells
@ast
Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells
@en
Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells
@nl
prefLabel
Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells
@ast
Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells
@en
Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells
@nl
P2093
P2860
P356
P1476
Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6690766
P407
P577
1999-11-01T00:00:00Z
P5875
P6179
1051735067